Biotech Investors & VC Firms in North America
272 firms in this list, with a median first check of $500K. 65 of them lead rounds. Generated from verified public data and updated continuously.
OneVentures
SydneySeed–Late Stage$3.3M – $13.2M
11 people
Ontario Centre of Innovation programs
TorontoPre-Seed–Growth
19 people
Samsara BioCapital
Palo AltoSeed–Late Stage
3 people
Apollo Health Ventures
BerlinSeed–Series A
32 people
Cloud Health Euroventures
NewarkPre-Seed–Series A$100K – $1M
21 people
XGEN Venture
MilanPre-Seed–Series A
21 people
Vanedge Capital Limited Partnership
VancouverSeed–Series A
10 people
Odyssey Investment Partners
New YorkGrowth–Late Stage$100M – $300M
14 people
Big Pi Ventures
AthensPre-Seed–Growth$540K – $3.2M
19 people
Lunar Ventures
BerlinPre-Seed–Seed$500K – $2M
14 people
Ocean Azul Partners
Coral GablesSeed–Series A$500K – $2M
8 people
Sixty Degree Capital
North YorkPre-Seed–Late Stage
16 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
Shoreline Venture Management
San Francisco Bay AreaSeed–Growth$250K – $8M
13 people
SVG Ventures | THRIVE
Silicon ValleyPre-Seed–Series A
23 people
TPG
Fort WorthGrowth–Late Stage
16 people
Teralys Capital
MontrealGrowth
22 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
9 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
OMERS Private Equity Inc.
TorontoGrowth–Late Stage
20 people
Xeraya Capital
Kuala LumpurSeed–Growth
20 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
19 people
Blindspot Ventures Management Co
BostonPre-Seed–Late Stage
8 people
Related lists
Crypto & Web3 Investors & VC Firms (4538)Investors & VC Firms in United States (4128)Investors & VC Firms in Global (3505)SaaS Investors & VC Firms (3157)Fintech Investors & VC Firms (2971)AI & Machine Learning Investors & VC Firms (2858)Enterprise Software Investors & VC Firms (2712)Healthtech Investors & VC Firms (2708)Investors & VC Firms in Europe (2540)Consumer Investors & VC Firms (2073)
Data sourced from public filings and firms' own websites — see our methodology.








































































